Description
Why should I use this product Anterogen is known for cutting edge research in 3D Human Stem Cell On May 18 2020, Anterogen received US Approval for Regenerative Medicine Advanced Therapy (RMAT) Designation In 2018, our product received patents on Human Stem Cell Media from the US (No. US9874574B2), Europe (No. EP2425844B1), Japan, Israel, , Hong Kong, and more Since 2012, Anterogen has been a market authorisation holder for the use of Cupistem injection as an adipose-derived stem cell therapy All products of Anterogen have been clinically tested by university hospitals in Korea Our Human Stem Cell is proven to show stronger paracrine in stem cells that helps with t regeneration and active cell rejuvenation Country Of Origin: USA Manufacturer/Importer/Packed By: Anterogen